|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4375 | |
| C07D 498/22 | |||
| A61P 1/00 |
| (11) | Patento numeris | 2672970 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12745372.8 |
| Europos patento paraiškos padavimo data | 2012-02-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-12-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/024746 |
| Data | 2012-02-10 |
| (87) | Numeris | WO 2012/109605 |
| Data | 2012-08-16 |
| (30) | Numeris | Data | Šalis |
| 201161556649 P | 2011-11-07 | US | |
| 201161530905 P | 2011-10-18 | US | |
| 201261583024 P | 2012-01-04 | US | |
| 201161441902 P | 2011-02-11 | US |
| (72) |
PARENT, Stephan, US
McQUEEN, Lisa, US
ANDRES, Patricia, US
SCHIELDS, Paul, US
WU, Yiduo, US
DING, Fei, US
SMIT, Jared P., US
|
| (73) |
Salix Pharmaceuticals, Ltd.,
8510 Colonnade Center Drive, Raleigh, NC 27615,
US
|
| (54) | FORMS OF RIFAXIMIN AND USES THEREOF |
| FORMS OF RIFAXIMIN AND USES THEREOF |